P-055 Prospective evaluation for chemotherapy-induced nausea and vomiting in colorectal cancer receiving oxaliplatin-based chemotherapy of moderate emetic risk

Lignende værker

• Comparison of the Control of Nausea and Vomiting among Several Moderately Emetic-Risk Chemotherapy Regimens
  af: Iihara, Hirotoshi, et al.
  Udgivet: (2016)
• A Nationwide, Multicenter Registry Study of Antiemesis for Carboplatin‐Based Chemotherapy‐Induced Nausea and Vomiting in Japan
  af: Iihara, Hirotoshi, et al.
  Udgivet: (2019)
• 5-Hydroxytryptamine-3 receptor antagonist and dexamethasone as prophylaxis for chemotherapy-induced nausea and vomiting during moderately emetic chemotherapy for solid tumors: a multicenter, prospective, observational study
  af: Matsui, Reiko, et al.
  Udgivet: (2020)
• Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study
  af: Hayashi, Toshinobu, et al.
  Udgivet: (2018)
• Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy
  af: Smith, Lesley A, et al.
  Udgivet: (2015)